Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 · Nature Medicine · 4,152 citations
https://doi.org/10.1038/s41591-021-01377-8
D
Deborah Cromer
UNSW Sydney(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
10.2K
Citations
35
h-index
80
i10-index
Deborah Cromer is an academic researcher from UNSW Sydney. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & HIV Research and Treatment. The author has an h-index of 35, co-authored 103 publications.
ORCID: 0000-0002-5276-5094Papers by this author
worksOmicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
2021 · Nature · 1,170 citations
https://doi.org/10.1038/s41586-021-04387-1
Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
2023 · Nature Communications · 119 citations
https://doi.org/10.1038/s41467-023-37176-7
Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
2023 · The Lancet Microbe · 34 citations
https://doi.org/10.1016/s2666-5247(23)00194-5
A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library
2015 · Virology Journal · 15 citations
https://doi.org/10.1186/s12985-015-0280-x
Macrophages direct location-dependent recall of B cell memory to vaccination
2025 · Cell · 14 citations
https://doi.org/10.1016/j.cell.2025.04.005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat